Patents by Inventor Nadejda Valiaeva

Nadejda Valiaeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS
    Publication number: 20230287029
    Abstract: Compounds, including antiviral prodrugs, and pharmaceutical formulations including the compounds, which may be orally bioavailable or formulated for intramuscular injection. Methods for producing compounds, such as antiviral prodrugs. Methods for treating coronavirus and other RNA virus infection in mammals. Methods of producing a drug triphosphate.
    Type: Application
    Filed: July 24, 2021
    Publication date: September 14, 2023
    Inventors: Karl Y. Hostetler, James Beadle, Nadejda Valiaeva, Robert T. Schooley
  • Nucleotide analogs
    Patent number: 11572377
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: February 7, 2023
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20220395510
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: May 31, 2022
    Publication date: December 15, 2022
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide analogs
    Patent number: 11344555
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: May 31, 2022
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20220072004
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: November 10, 2021
    Publication date: March 10, 2022
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20220062289
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20210246153
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 12, 2021
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide analogs
    Patent number: 11014950
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: May 25, 2021
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20200316076
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide analogs
    Patent number: 10702532
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: July 7, 2020
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Acyclic Nucleoside Phosphonate Diesters
    Publication number: 20190388442
    Abstract: The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
    Type: Application
    Filed: September 11, 2019
    Publication date: December 26, 2019
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20190359638
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: August 8, 2019
    Publication date: November 28, 2019
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Acyclic nucleoside phosphonate diesters
    Patent number: 10449207
    Abstract: The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: October 22, 2019
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide analogs
    Patent number: 10377782
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: August 13, 2019
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide Analogs
    Publication number: 20190134048
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 9, 2019
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Nucleotide analogs
    Patent number: 10213430
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: February 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Acyclic nucleoside phosphonate diesters
    Patent number: 10195222
    Abstract: The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: February 5, 2019
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • Acyclic Nucleoside Phosphonate Diesters
    Publication number: 20180360859
    Abstract: The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 20, 2018
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
  • NUCLEOTIDE ANALOGS
    Publication number: 20180362561
    Abstract: Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
    Type: Application
    Filed: September 15, 2016
    Publication date: December 20, 2018
    Applicant: The Regents of the University of California
    Inventors: Karl Y. HOSTETLER, James R. BEADLE, Nadejda VALIAEVA
  • Acyclic nucleoside phosphonate diesters
    Patent number: 10076532
    Abstract: The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: September 18, 2018
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Nadejda Valiaeva